SI010191: Acalabrutinib Metabolite [AC-5862] label-new 2-Aminoethyl β-D-galactopyranoside

2-Aminoethyl β-D-galactopyranoside

The trivalent presentation of GalNAcβ residues engages multiple carbohydrate-recognition domains of ASGPR simultaneously

2-[2-(2-Azidoethoxy)ethoxy]ethyl α-D-mannose-6-phosphate

/ HHV1-gB(53-56)-STn(53) / HHV1P

This compound enables the construction of hepatocyte-targeted therapeutics and research tools that exploit the asialoglycoprotein receptor (ASGPR

SI010191: Acalabrutinib Metabolite [AC-5862] label-new 2-Aminoethyl β-D-galactopyranosideC26H23N7O2 481. 53 Acalabrutinib Metabolite [AC 5862] AC 5862; 4 [8 Amino 3 [1 oxo 4 [(1 oxo 2 butyn 1 yl)amino]butyl]imidazo[1,5 a]pyrazin 1 yl] N 2 pyridinyl benzamide